[The pharmacokinetical analysis of the fate of naphtidrofuryl oxalate (LS121) in human subjects. II. Estimation of the first-pass effect after oral administration].
D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D005260:Female; D005663:Furans / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D009257:Nafronyl / Q000008:administration & dosage / Q000378:metabolism*
D005663:Furans; D009257:Nafronyl